The Role of the Skin and Gut Microbiome in Psoriatic Disease

Current Dermatology Reports

Volumn 6, Issue 2, 2017, Pages 94-103

  Yan, Di ^a   Issa, Naiem ^b   Afifi, Ladan ^a   Jeon, Caleb ^a   Chang, Hsin Wen ^a   Liao, Wilson ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gut bacteria; Microbiome; Mycobiome; Psoriasis; Psoriatic arthritis; Skin microbiota

Indexed keywords

ACTINOBACTERIA; BACTEROIDETES; BIFIDOBACTERIUM; BIOINFORMATICS; CLUSTER ANALYSIS; DISEASE ASSOCIATION; FIRMICUTES; GENE LIBRARY; HUMAN; INTESTINE FLORA; MALASSEZIA; MICROBIAL DIVERSITY; MICROBIAL GROWTH; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPIONIBACTERIUM; PSORIASIS; PYROSEQUENCING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RUMINOCOCCUS; SKIN FLORA; STAPHYLOCOCCUS; STREPTOCOCCUS; SYSTEMATIC REVIEW; VERRUCOMICROBIA; WART VIRUS; WHOLE GENOME SEQUENCING;

EID: 85043469966     PISSN: None     EISSN: 21624933     Source Type: Journal    
DOI: 10.1007/s13671-017-0178-5     Document Type: Review

References (70)

1. Clements SJ, Carding SR. Diet, the intestinal microbiota and immune health in ageing. Crit Rev food Sci Nutr. 2016; doi:10.1080/10408398.2016.1211086.
2. Cheng J, Palva AM, de Vos WM, et al. Contribution of the intestinal microbiota to human health: from birth to 100 years of age. Curr Top Microbiol Immunol. 2013;358:323–46. doi:10.1007/82_2011_189.
3. Scher JU, Littman DR, Abramson SB. Microbiome in inflammatory arthritis and human rheumatic diseases. Arthritis & Rheumatology (Hoboken, NJ). 2016;68(1):35–45. doi:10.1002/art.39259.
4. Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13(4):260–70. doi:10.1038/nrg3182.
5. David LA, Materna AC, Friedman J, et al. Host lifestyle affects human microbiota on daily timescales. Genome Biol. 2014;15(7):R89. doi:10.1186/gb-2014-15-7-r89.
6. Salim SY, Kaplan GG, Madsen KL. Air pollution effects on the gut microbiota: a link between exposure and inflammatory disease. Gut Microbes. 2014;5(2):215–9. doi:10.4161/gmic.27251.
7. Yeoh N, Burton JP, Suppiah P, et al. The role of the microbiome in rheumatic diseases. Curr Rheumatol Rep. 2013;15(3):314. doi:10.1007/s11926-012-0314-y.
8. Longman RS, Littman DR. The functional impact of the intestinal microbiome on mucosal immunity and systemic autoimmunity. Curr Opin Rheumatol. 2015;27(4):381–7. doi:10.1097/bor.0000000000000190.
9. Costello EK, Lauber CL, Hamady M, et al. Bacterial community variation in human body habitats across space and time. Science (New York, NY). 2009;326(5960):1694–7. doi:10.1126/science.1177486.
10. Grice EA, Kong HH, Renaud G, et al. A diversity profile of the human skin microbiota. Genome Res. 2008;18(7):1043–50. doi:10.1101/gr.075549.107.
11. Peterson J, Garges S, Giovanni M, et al. The NIH Human Microbiome Project. Genome Res. 2009;19(12):2317–23. doi:10.1101/gr.096651.109.
12. Aagaard K, Petrosino J, Keitel W, et al. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2013;27(3):1012–22. doi:10.1096/fj.12-220806.
13. Fahlen A, Engstrand L, Baker BS, et al. Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch Dermatol Res. 2012;304(1):15–22. doi:10.1007/s00403-011-1189-x.
14. Drago L, De Grandi R, Altomare G, et al. Skin microbiota of first cousins affected by psoriasis and atopic dermatitis. Clinical and molecular allergy: CMA. 2016;14:2. doi:10.1186/s12948-016-0038-z.
15. Gao Z, Tseng CH, Strober BE, et al. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One. 2008;3(7):e2719. doi:10.1371/journal.pone.0002719.
16. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244–53. doi:10.1038/nrmicro2537.
17. Jovel J, Patterson J, Wang W, et al. Characterization of the gut microbiome using 16S or shotgun metagenomics. Front Microbiol. 2016;7:459. doi:10.3389/fmicb.2016.00459.
18. Meisel JS, Hannigan GD, Tyldsley AS, et al. Skin microbiome surveys are strongly influenced by experimental design. The Journal of investigative dermatology. 2016;136(5):947–56. doi:10.1016/j.jid.2016.01.016.
19. Zakostelska Z, Malkova J, Klimesova K, et al. Intestinal microbiota promotes psoriasis-like skin inflammation by enhancing Th17 response. PLoS One. 2016;11(7):e0159539. doi:10.1371/journal.pone.0159539.
20. Horton DB, Scott FI, Haynes K, et al. Antibiotic exposure, infection, and the development of pediatric psoriasis: a nested case-control study. JAMA dermatology. 2016;152(2):191–9. doi:10.1001/jamadermatol.2015.3650.
21. • Alekseyenko AV, Perez-Perez GI, De Souza A, et al. Community differentiation of the cutaneous microbiota in psoriasis. Microbiome. 2013;1(1):31. doi:10.1186/2049-2618-1-31. Here Alekseyenko et al. report the results of the largest study profiling the cutaneous microbiome in psoriasis to date. This study is also the only one to profile changes in the cutaneous microbiome after treatment for psoriasis.
22. Paulino LC, Tseng CH, Strober BE, et al. Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J Clin Microbiol. 2006;44(8):2933–41. doi:10.1128/jcm.00785-06.
23. Paulino LC, Tseng CH, Blaser MJ. Analysis of Malassezia microbiota in healthy superficial human skin and in psoriatic lesions by multiplex real-time PCR. FEMS Yeast Res. 2008;8(3):460–71. doi:10.1111/j.1567-1364.2008.00359.x.
24. Jagielski T, Rup E, Ziolkowska A, et al. Distribution of Malassezia species on the skin of patients with atopic dermatitis, psoriasis, and healthy volunteers assessed by conventional and molecular identification methods. BMC Dermatol. 2014;14:3. doi:10.1186/1471-5945-14-3.
25. Takemoto A, Cho O, Morohoshi Y, et al. Molecular characterization of the skin fungal microbiome in patients with psoriasis. J Dermatol. 2015;42(2):166–70. doi:10.1111/1346-8138.12739.
26. Wolf P, Seidl H, Back B, et al. Increased prevalence of human papillomavirus in hairs plucked from patients with psoriasis treated with psoralen-UV-A. Arch Dermatol. 2004;140(3):317–24. doi:10.1001/archderm.140.3.317.
27. Simeone P, Teson M, Latini A, et al. Human papillomavirus type 5 in primary keratinocytes from psoriatic skin. Exp Dermatol. 2005;14(11):824–9. doi:10.1111/j.1600-0625.2005.00358.x.
28. Cronin JG, Mesher D, Purdie K, et al. Beta-papillomaviruses and psoriasis: an intra-patient comparison of human papillomavirus carriage in skin and hair. Br J Dermatol. 2008;159(1):113–9. doi:10.1111/j.1365-2133.2008.08627.x.
29. Salem SA, Zuel-Fakkar NM, Fathi G, et al. Comparative study of human papilloma virus in untreated and ultraviolet-treated psoriatic patients. Photodermatology, photoimmunology & photomedicine. 2010;26(2):78–82. doi:10.1111/j.1600-0781.2010.00492.x.
30. de Koning MN, Polderman MC, Waterboer T, et al. Marked differences in Betapapillomavirus DNA and antibody prevalence between patients with psoriasis and those with atopic dermatitis. Br J Dermatol. 2011;164(4):771–5. doi:10.1111/j.1365-2133.2010.10182.x.
31. Bellaud G, Gheit T, Pugin A, et al. Prevalence of human papillomavirus DNA in eyebrow hairs plucked from patients with psoriasis treated with TNF inhibitors. Journal of the European Academy of Dermatology and Venereology: JEADV. 2014;28(12):1816–20. doi:10.1111/jdv.12308.
32. Prignano G, Ferraro C, Mussi A, et al. Prevalence of human papilloma virus type 5 DNA in lesional and non-lesional skin scales of Italian plaque-type psoriatic patients: association with disease severity. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2005;11(1):47–51. doi:10.1111/j.1469-0691.2004.01040.x.
33. Masallat D, Moemen D, State AF. Gut bacterial microbiota in psoriasis: a case control study. Afr J Microbiol Res. 2016;10(33):1337–43. doi:10.5897/AJMR2016.8046.
34. • Scher JU, Ubeda C, Artacho A, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis & rheumatology (Hoboken, NJ). 2015;67(1):128–39. doi:10.1002/art.38892. The study by Scher et al., is the only comprehensive, genus-level, profiling study of the gut microbiome in psoriatic disease to date. This study is also significant in that it correlates fecal metabolites with shifts in gut microbiome composition, providing the foundation for a mechanistic understanding of how bacteria can influence the host.
35. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol. 2000;61(3):289–97.
36. Struijk L, Bouwes Bavinck JN, Wanningen P, et al. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. The Journal of investigative dermatology. 2003;121(6):1531–5. doi:10.1046/j.1523-1747.2003.12632.x.
37. Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol. 2002;138(5):649–54.
38. Sahebjamiee M, Sand L, Karimi S, et al. Prevalence of human papillomavirus in oral lichen planus in an Iranian cohort. Journal of oral and maxillofacial pathology: JOMFP. 2015;19(2):170–4. doi:10.4103/0973-029x.164528.
39. Dekio I, Hayashi H, Sakamoto M, et al. Detection of potentially novel bacterial components of the human skin microbiota using culture-independent molecular profiling. J Med Microbiol. 2005;54(Pt 12):1231–8. doi:10.1099/jmm.0.46075-0.
40. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (New York, NY). 2013;341(6145):569–73. doi:10.1126/science.1241165.
41. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313–23. doi:10.1038/nri2515.
42. Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, et al. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol. 2003;149(3):530–4.
43. Naik S, Bouladoux N, Linehan JL, et al. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature. 2015;520(7545):104–8. doi:10.1038/nature14052.
44. Schirmer M, Smeekens SP, Vlamakis H, et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167(4):1125–36.e8. doi:10.1016/j.cell.2016.10.020.
45. Cantini F, Niccoli L, Nannini C, et al. Psoriatic arthritis: a systematic review. Int J Rheum Dis. 2010;13(4):300–17. doi:10.1111/j.1756-185X.2010.01540.x.
46. Calcinaro F, Dionisi S, Marinaro M, et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia. 2005;48(8):1565–75. doi:10.1007/s00125-005-1831-2.
47. Lavasani S, Dzhambazov B, Nouri M, et al. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One. 2010;5(2):e9009. doi:10.1371/journal.pone.0009009.
48. Groeger D, O’Mahony L, Murphy EF, et al. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes. 2013;4(4):325–39. doi:10.4161/gmic.25487.
49. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63. doi:10.1038/nature09922.
50. Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576–85. doi:10.1038/nm.3145.
51. Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–84. doi:10.1056/NEJMoa1109400.
52. Cho CE, Taesuwan S, Malysheva OV, et al. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial. Mol Nutr Food Res. 2016; doi:10.1002/mnfr.201600324.
53. Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–3. doi:10.1038/4441022a.
54. Duarte GV, Silva LP. Correlation between psoriasis’ severity and waist-to-height ratio. An Bras Dermatol. 2014;89(5):846–7.
55. Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutrition & diabetes. 2012;2:e54. doi:10.1038/nutd.2012.26.
56. Toussirot E, Aubin F, Dumoulin G. Relationships between adipose tissue and psoriasis, with or without arthritis. Front Immunol. 2014;5:368. doi:10.3389/fimmu.2014.00368.
57. Abuabara K, Azfar RS, Shin DB, et al. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol. 2010;163(3):586–92. doi:10.1111/j.1365-2133.2010.09941.x.
58. Gelfand JM, Yeung H. Metabolic syndrome in patients with psoriatic disease. The Journal of rheumatology Supplement. 2012;89:24–8. doi:10.3899/jrheum.120237.
59. De Preter V, Machiels K, Joossens M, et al. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015;64(3):447–58. doi:10.1136/gutjnl-2013-306423.
60. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146(6):1489–99. doi:10.1053/j.gastro.2014.02.009.
61. Eppinga H, Konstantinov SR, Peppelenbosch MP, et al. The microbiome and psoriatic arthritis. Curr Rheumatol Rep. 2014;16(3):407. doi:10.1007/s11926-013-0407-2.
62. Mueller S, Saunier K, Hanisch C, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol. 2006;72(2):1027–33. doi:10.1128/aem.72.2.1027-1033.2006.
63. Markle JG, Frank DN, Adeli K, et al. Microbiome manipulation modifies sex-specific risk for autoimmunity. Gut Microbes. 2014;5(4):485–93. doi:10.4161/gmic.29795.
64. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–63. doi:10.1038/nature12820.
65. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14. doi:10.1038/nature11234.
66. O’Dell JR, Elliott JR, Mallek JA, et al. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone. Arthritis Rheum. 2006;54(2):621–7. doi:10.1002/art.21620.
67. Tilley BC, Alarcon GS, Heyse SP, et al. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med. 1995;122(2):81–9.
68. Lee CH, Steiner T, Petrof EO, et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA. 2016;315(2):142–9. doi:10.1001/jama.2015.18098.
69. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279–90. doi:10.1056/NEJMoa1200303.
70. Wang X, Thijssen B, Yu H. Target essentiality and centrality characterize drug side effects. PLoS Comput Biol. 2013;9(7):e1003119. doi:10.1371/journal.pcbi.1003119.